Condition
Coronary Artery Disease (CAD) clinical trials and research
As of November 12, 2026, Find a Trial lists 39 Coronary Artery Disease (CAD) clinical trials that are recruiting, at sites in 20 countries (most in China (8), Netherlands (4), Turkey (Türkiye) (4)). 1 was first registered in the last 30 days. By phase: Phase 3 (2), Phase 4 (1), Phase 2 (1). The most active sponsors are China National Center for Cardiovascular Diseases (3), TC Erciyes University (2), HeartFlow, Inc. (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 39Clinical trials
- 1New in 30 days
- 20Countries
Newest Coronary Artery Disease (CAD) clinical trials
All recruiting trials (39)
-
TAVI and PCI vs SAVR and CABG in low- and intermediate-risk patients with severe aortic stenosis and CAD
This observational study compares TAVI plus PCI to SAVR plus CABG for patients who have both severe aortic stenosis and coronary artery disease.
-
Resveratrol and Estrogen Receptors in Postmenopausal Women with CAD
This study tests whether taking resveratrol is safe and can change estrogen-related markers in postmenopausal women with coronary artery disease.
-
Predicting Plaque Growth Using Blood Flow Stress Markers
This study tests whether combining blood flow patterns in the heart arteries with how blood-flow–sensitive cells respond can help predict which plaques will grow in people with coronary artery disease.
-
Identifying Coronary Plaque Traits with Photon-counting CT and Multimodality Imaging
This study tests whether advanced imaging can better identify risky artery plaques in people with stable angina.
-
Health for Hungary: Long-term blood and health data collection to study aging and disease onset
This study tests whether routine blood tests plus advanced molecular analyses can help detect the early stages of non-communicable diseases in adults over 40.
-
Coronary Extension Catheter in PCI for CAD patients
This study tests whether using a coronary extension catheter during PCI helps adults with coronary artery disease.
-
Cardiac rehab in CAD: does it affect ferroptosis?
This study tests whether a structured cardiac rehabilitation program changes ferroptosis markers in people with coronary artery disease compared with those who don’t participate and healthy volunteers.
-
IVUS-Guided Left Main Stenting: IVUS-Guided vs Trained-Eye Approach
This trial tests whether using IVUS to guide left main bifurcation stenting is as good as using an angiography-driven, experience-based approach by an IVUS-savvy operator.
-
Mobile-based home cardiac rehab to see if it reduces non-calcified coronary plaque
A mobile, at-home cardiac rehabilitation program is being tested to see if it can reduce non-calcified plaque in people with mild to moderate coronary artery narrowing.
-
Effects of Myofascial Release on Heart Patients After Sternotomy
This study tests whether myofascial release can improve breathing and chest mobility after heart surgery in adults with certain heart diseases.
-
Crossover vs Accurate Ostial Stenting for Left Main Bifurcation Lesions
This observational study tests two stenting strategies for ostial lesions in the left main coronary artery to see which approach works better for patients with left main bifurcation disease.
-
eCardiacRehab: a home-based, patient-centered cardiac rehab program
This trial tests a hybrid home-based cardiac rehabilitation program to see if it reduces cardiovascular deaths and ED visits while improving quality of life for adults with CAD after PCI, compared with usual care.
-
AI-assisted cardiac CT to predict coronary artery disease risk
This project will try using AI-enhanced heart CT scans to better predict future coronary events in adults who are already getting a clinical cardiac CT.
-
Paired intracoronary OCT and coronary CT angiography to map plaque and blockages
This project will test whether advanced coronary CT scans can provide the same detailed plaque and blockage information as invasive intracoronary optical coherence tomography (OCT) in adults with coronary artery disease who have both scans.
-
Multi-omics search for clotting and bleeding markers in coronary heart disease
This project will test whether combining proteins, metabolites, genes, sugar tags, and heart images can better predict clotting and major bleeding in people with coronary heart disease on dual antiplatelet therapy.
-
Inspiron EVO stent in complex coronary lesions in Brazil
This study tests how well and safely the Inspiron EVO drug-eluting stent works in real-world patients with complex coronary artery disease in Brazil.
-
NAVIGATE-PCI: Using CT images to guide planning for elective stenting.
This registry will try CT-based PCI Navigator guidance to see if it helps cardiologists plan elective stenting for patients with stable coronary artery disease.
-
Fexuprazan to prevent upper gastrointestinal bleeding in high-bleeding-risk patients on dual antiplatelet therapy after stent placement
This will test whether taking fexuprazan once daily for six months reduces upper gastrointestinal bleeding in people at high bleeding risk who need dual antiplatelet therapy after coronary stent placement.
-
Better care for people with recent-onset stable chest pain
This project will test a new nationwide care model that uses coronary CT instead of routine cardiac catheterization for adults 30 and older with recent-onset stable chest pain to see if it lowers heart attacks, strokes, and healthcare costs.
-
Drug-coated balloons versus drug-eluting stents for chronic total occlusion of coronary arteries
This will test whether using drug-coated balloons (alone or with a stent when needed) works as well as drug-eluting stents alone for people whose chronically blocked coronary artery has been successfully opened.
-
Erectile function changes after coronary stent procedures for heart attack versus stable angina
We will see if erectile function gets better or worse over 3 and 6 months in men who had a successful PCI (stent procedure) for a heart attack or for stable angina.
-
Using wearable data to predict heart health and cardiovascular risk
This will test whether continuous Fitbit data can help track and predict heart health and future cardiovascular risk in adults.
-
Using the ulnar artery when the same-arm radial artery is blocked for heart angiography or angioplasty
This study will try using the ulnar artery in the same arm with a blocked radial artery to see if it's safe and how it affects hand strength, feeling, and everyday hand use in adults having coronary angiography or angioplasty.
-
Mindfulness for Women with Coronary Artery Disease
This study tests whether a mindfulness-based program helps women with coronary artery disease reduce stress and improve quality of life.
-
Drug-coated balloon vs. drug-eluting stent in high-risk coronary artery disease
This trial tests whether a SeQuent SCB strategy can match the performance of a new-generation DES in high-risk CAD patients, over 12 and 36 months.
-
EA-230 to shorten hospital stay after CABG surgery in adults
EA-230 is being tested to see if it helps adults recovering from CABG surgery by shortening their hospital stay.
-
Low-dose colchicine for people with non-flow-limiting coronary plaque seen on CT
This trial tests whether taking 0.5 mg of colchicine once daily on top of usual heart medicines can lower the chance of heart attack, stroke, or need for coronary procedures in adults with stable coronary artery disease and non-flow-limiting plaques on coronary CT.
-
SRSD107 for people with chronic coronary or peripheral arterial disease
This trial will test different doses of SRSD107 to see if they are safe and produce the expected drug effects in adults with chronic coronary or peripheral arterial disease who are taking aspirin.
-
Best way to fix under‑expanded coronary stents in resistant blockages
This compares intravascular lithotripsy (IVL) with high‑pressure or specialty balloons to see if IVL opens under‑expanded coronary stents better in people with in‑stent restenosis.
-
Multivessel Hybrid Revascularization for Three-Vessel CAD vs Conventional Off-Pump CABG
This trial tests whether a minimally invasive multivessel hybrid revascularization (LAD and circumflex grafted via a small thoracotomy plus PCI for the RCA) is better than traditional off-pump CABG done through sternotomy in people with three-vessel coronary disease.
-
AI facial-photo screening for coronary artery disease in high-risk community members
This project tests whether an AI algorithm can use a facial photo to screen for coronary artery disease in people with diabetes, high blood pressure, or over age 65.
-
Bypass surgery versus stents for people with weak heart pumping and blockages in multiple coronary arteries
This trial tests whether bypass surgery (CABG) or stents (PCI) lead to better survival, fewer major heart problems, and improved quality of life for adults with reduced left ventricular function (LVEF ≤40%) and multivessel coronary disease.
-
Monitoring coronary artery plaque progression in people with type 2 diabetes.
This project will follow adults with type 2 diabetes who already had a coronary CT angiography to see how plaque in their heart arteries changes over time.
-
Very short DAPT after PCI in older adults
This trial tests whether stopping aspirin after 7 days of dual antiplatelet therapy is as safe and effective as continuing DAPT for 3 to 12 months in people 65 and older who had a PCI with drug-eluting stents.
-
Assessing heart disease risk in former NFL players
This study looks at heart disease risk in retired NFL players by checking their heart health with special scans to see how their past as professional athletes affects them.
-
Three-vessel ultrasonic flow ratio to predict one-year heart risk in people with coronary artery disease
This will test if measuring the ultrasonic flow ratio in all three coronary arteries can help predict one-year risk of major heart problems in adults with coronary artery disease who have at least 30% narrowing in each artery.
-
Registry for assessing QFR analysis in coronary artery disease
This study is testing if a new method called QFR for checking blood flow in heart arteries can be used effectively by less experienced doctors during routine procedures for patients with coronary artery disease.
-
Post-market follow-up of Coroflex® ISAR NEO coronary stent system
This study is testing how safe and effective the Coroflex® ISAR NEO stent is for patients who need it in real-life situations.
-
Post-market follow-up for the SUPRAFLEX CRUZ stent in patients with coronary artery disease
This study is testing how well the SUPRAFLEX CRUZ stent works and if it's safe for people with coronary artery disease who are getting treated in real-life hospital settings.
Related topics
Quick answers
How many Coronary Artery Disease (CAD) clinical trials are recruiting right now?
39, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 20 countries. The most sites are in China (8 trials), Netherlands (4 trials), Turkey (Türkiye) (4 trials), United Kingdom (4 trials), France (3 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 2, Phase 4: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.